Actinogen Medical Is A Biotechnology Company Listed On The Australian Securities Exchange Under The Ticker Acwthe Company Specializes In Developing Innovative Therapies For Neurological And Neuropsychiatric Diseasesparticularly Those Related To Dysregulated Brain Cortisolactinogen Aims To Enhance The Quality Of Life For Patients And Their Families By Providing Effective Treatments The Company S Lead Compoundxanamemalso Known As Emestedastat Is A Once Daily Oral Medication Designed To Lower Cortisol Levels In The Brainxanamem Is Being Evaluated For Its Potential To Treat Alzheimer S Diseasewith Ongoing Trials Focusing On Early Stage Patientsit Is Also Being Tested For Its Ability To Address Cognitive Impairment In Major Depressive Disorder Through The Xanacidd Trialactinogen Is Open To Partnerships For Further Researchincluding Indications Like Fragile X Syndrome Actinogen Actively Engages In Clinical Trials And Researchpresenting Findings At International Conferences And Hosting Webinars To Discuss Advancements In Alzheimerae S Treatmentsthe Company Collaborates With Healthcare Professionals And Regulatory Authorities To Ensure Compliance And Support The Commercialization Of Its Therapies
